Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgel for Hypoactive Sexual Desire Disorder in Women
NCT00140153Phase 3Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in hypoactive sexual desire disorder (HSDD), sponsored by Be'er Sheva Mental Health Center. Started Apr 2005; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00140153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140153.